AuntMinnie

JANUARY 30, 2024

MRI is the imaging gold standard for diagnosis, yet identifying the disease using this method remains challenging, the researchers wrote. In all three cases, gadolinium-enhanced MRI scans did not show abnormalities. In our outpatient clinic follow-up (2 to 2.5

Diagnose 108

Diagnose PET Scan MRI Disease 108

Imaging Technology

MAY 31, 2023

We can’t treat what we don’t see, which is why we require precise image quality to help diagnose, plan treatment for, and monitor disease,” explains Prof. Medical imaging is a crucial tool for diagnosing disease, identifying a course of treatment, and determining whether therapy is successful for millions of patients around the world.

Nuclear Medicine 86

Nuclear Medicine Healthcare Healthcare IT 86

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

AuntMinnie

APRIL 15, 2024

FAPI-PET either confirmed or ruled out the disease in all cases, the group found. Our results suggest that supplemental Ga-68 FAPI-46 PET may improve the noninvasive assessment of primary pulmonary lesions compared with F-18 FDG-PET and CT alone,” wrote lead author Manuel Röhrich, MD, and colleagues.

Nuclear Medicine 122

Nuclear Medicine PET Scan Hospital Clinic 122

Imaging Technology

MAY 2, 2023

The ability to determine the extent and location of recurrent prostate cancer to inform appropriate clinical management for these men is key for physicians and their patients, because up to 50% of patients who undergo radiation therapy will develop local or distant recurrences within 10 years,” said Brian T. 2022; 40 (6_suppl):9-9.

Diagnostic 93

Diagnostic Radiopharmaceuticals Imaging Radiation 93